Drug Safety
Subscribe to Drug Safety

The Lead

Survey Finds Sharp Increase in Teen HGH Use

July 23, 2014 1:31 pm | by David Crary, AP National Writer | News | Comments

Experimentation with human growth hormones by America's teens more than doubled in the past year, as more young people looked to drugs to boost their athletic performance and improve their looks, according to a new survey. Read more...     

Halozyme Resumes Pancreatic Cancer Trial

July 22, 2014 2:37 pm | News | Comments

Halozyme Therapeutics Inc. announced that it has resumed enrollment and dosing of patients in...

Easing Drug-Induced Fatty Liver Disease in HIV Patients

July 22, 2014 1:40 pm | News | Comments

The only drug to receive FDA approval for reduction of the abdominal fat deposits that develop...

Studies Reveal New Niacin Risks

July 17, 2014 10:54 am | by Marilynn Marchione, AP Chief Medical Writer | News | Comments

New details from two studies reveal more side effects from niacin, a drug that hundreds of...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Tamoxifen Gel Effective When Applied to Breast

July 15, 2014 3:08 pm | News | Comments

A breakdown product of tamoxifen, 4-OHT, applied as a gel formulation on the breasts of women with ductal carcinoma in situ (DCIS), was as effective in reducing cell proliferation as oral tamoxifen, with fewer side effects compared with oral tamoxifen, according to a study. Read more...

Significant Increase in Antibiotic Use Across the World, Study Shows

July 11, 2014 3:23 pm | News | Comments

Global use of antibiotics is surging, according to researchers who have conducted a broad assessment of antibiotic consumption around the world. Read more...                            

Compounding Pharmacy Oversight Changes Signed

July 11, 2014 2:38 pm | News | Comments

Two years after a deadly nationwide meningitis outbreak linked to a compounding pharmacy in Massachusetts, Gov. Deval Patrick on Thursday signed a law he said would address a "gray area" between state and federal oversight of the pharmacies. Read more...


Review: Gaps Between Approval, Safety Assessment of ADHD Drugs

July 10, 2014 12:00 pm | News | Comments

Over the last 60 years, the FDA approved 20 medications for ADHD based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events, researchers report. Read more...        

Childhood Vaccines Again Deemed Generally Safe

July 1, 2014 1:29 pm | by Mike Stobbe, AP Medical Writer | News | Comments

The latest analysis of childhood vaccines confirms they're generally safe. The report should be reassuring to parents, the researchers say. For example, there still is no evidence the measles-mumps-rubella vaccine causes autism. Nor is there any proof vaccines cause childhood leukemia. Read more...

FDA Warns of Allergic Reactions With Acne Products

June 26, 2014 1:05 pm | by Matthew Perrone, AP Health Writer | News | Comments

Federal health officials are warning consumers who use popular anti-acne treatments about rare but potentially deadly allergic reactions that can cause swelling of the face and difficulty breathing. Read more...            

Committee Recommends Nixing Cardiovascular Outcomes Trial for PAMORA Drugs

June 13, 2014 10:40 am | News | Comments

AstraZeneca announced that the majority of FDA Anesthetic and Analgesic Drug Products Advisory Committee members voted that the FDA should not require cardiovascular outcomes trials for the peripherally-acting mu-opioid receptor antagonist (PAMORA) class of drugs, which includes AstraZeneca's Movantik. Read more...

'Fight the Fakes' Campaign Gains New Partners

June 6, 2014 9:40 am | News | Comments

Following the campaign's six-month anniversary, Fight the Fakes announced that eleven new partners joined the campaign to speak up and spread the word about the devastating impact of fake medicines. Read more...           


Merck's NuvaRing Settlement Finalized at $100M

June 6, 2014 8:18 am | by Jim Salter | News | Comments

A $100 million settlement involving NuvaRing, a birth-control device linked to sometimes-fatal side effects, will stand now that the vast majority of claimants have chosen to opt into the agreement. Read more...           

Janssen Withdraws EU App for IV Administered Simponi

May 19, 2014 10:42 am | News | Comments

Janssen Biologics B.V. announced that the company has withdrawn its application seeking a change to the Marketing Authorization for Simponi to add a new pharmaceutical form of intravenous administration for the treatment of adults with moderately to severely active rheumatoid arthritis. Read more...

Pradaxa Carries Higher Risk for GI Bleeding than Warfarin

May 14, 2014 10:36 am | News | Comments

The FDA recently completed a new study in Medicare patients comparing Boehringer Ingelheim's Pradaxa to warfarin, and found that  Pradaxa was associated with a lower risk of clot-related strokes, bleeding in the brain and death, but carried and increased risk of major gastrointestinal bleeding. Read more...

Aspirin Could Combat Hearing Loss Caused by Cancer Drug

May 8, 2014 8:30 am | News | Comments

A new trial investigating whether high doses of aspirin can help prevent permanent hearing loss, a common side effect among cancer patients given the chemotherapy drug cisplatin, launched Thursday in the UK. Read more...         

Merck, Endocyte Halt Ovarian Cancer Trial

May 2, 2014 9:51 am | News | Comments

Merck and Endocyte Inc. announced that the Data Safety Monitoring Board of the PROCEED trial has recommended that the trial be stopped because vintafolide did not demonstrate efficacy on the pre-specified outcome of Progression-Free Survival in patients with platinum-resistant ovarian cancer. Read more...


Merck, Endocyte Halt Ovarian Cancer Trial

May 2, 2014 9:51 am | News | Comments

Merck and Endocyte Inc. announced that the Data Safety Monitoring Board of the PROCEED trial has recommended that the trial be stopped because vintafolide did not demonstrate efficacy on the pre-specified outcome of Progression-Free Survival in patients with platinum-resistant ovarian cancer. Read more...

Zogenix Focuses on Abuse-Resistant Forms of Painkiller

April 28, 2014 12:19 pm | News | Comments

The San Diego company that makes the powerful new prescription painkiller Zohydro is selling off its migraine therapy business to focus on developing abuse-resistant forms of Zohydro, because health officials worry addicts will crush Zohydro capsules and then snort or inject the drug. Read more...

FDA to Convene Public Meeting on Chantix

April 25, 2014 1:31 pm | by Matthew Perrone, AP Health Writer | News | Comments

The Food and Drug Administration announced Friday it will convene a public meeting in October to review the risks of psychiatric and behavioral side effects (hostility, agitation, depression and suicidal thoughts) with Pfizer's anti-smoking drug Chantix. Read more...

Daiichi Sankyo Halts Lung Cancer Trial

April 25, 2014 2:28 am | News | Comments

Daiichi Sankyo Co. Ltd. announced the discontinuation of the Phase 3 clinical trial conducted in Japan for nimotuzumab in lung cancer, based on safety issues. Read more...                     

$14M Awarded in Suit Linking Yasmin, Stroke

April 21, 2014 10:01 am | News | Comments

A jury has awarded $14 million to a suburban Chicago woman who sued her doctor over a debilitating stroke she suffered after taking Bayer's birth control drug Yasmin. Read more...                 

Breaking News: Cubist Recalls Cubicin Lot

April 18, 2014 2:02 pm | News | Comments

Cubist Pharmaceuticals Inc. announced it is voluntarily recalling one lot of Cubicin (daptomycin for injection) to the user level due to the presence of particulate matter, reported via customer complaint and identified as glass particles. Read more...

NIH Awards Scripps $2M to Design a Better Diabetes Drug Model

April 17, 2014 1:21 pm | News | Comments

Scientists from the Florida campus of TSRI have been awarded $2.1 million from the NIH to study the therapeutic potential of safer and more effective alternatives to the current crop of anti-diabetic drugs, which have been limited in their use due to side effects including bone loss and CHF. Read more...

SSRI Use During Pregnancy Linked to Autism, Developmental Delays

April 16, 2014 10:57 am | News | Comments

In a study of nearly 1,000 mother-child pairs, researchers found that prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) was associated with autism spectrum disorder (ASD) and developmental delays (DD) in boys. Read more...   

Judge Blocks Zohydro Ban in Massachusetts

April 16, 2014 10:47 am | by Steve LeBlanc | News | Comments

A federal judge has blocked Massachusetts from banning the powerful new painkiller Zohydro after the maker of the drug, Zogenix, argued in a lawsuit that the ban ordered by Gov. Deval Patrick last month is unconstitutional. Read more...    

Breaking News: EMA Warns of Falsified Herceptin

April 16, 2014 9:09 am | News | Comments

The EMA has been informed that vials of the cancer medicine Herceptin, thought to have been stolen in Italy, including from hospitals, have been tampered with and re-introduced under false credentials into the supply chain in some countries. Read more...

Yeast Provides Genetic Clues to Drug Response

April 11, 2014 10:45 am | News | Comments

Why do people respond differently to the same drug? For the first time, researchers have untangled genetic and environmental factors related to drug reactions, bringing us a step closer to predicting how a drug will affect us. Read more...   

Affimed’s Lymphoma Drug Shows Favorable Safety Profile, Activity

April 10, 2014 3:15 pm | News | Comments

Affimed Therapeutics AG announced further results from its Phase 1 clinical trial of AFM13 (a bispecific T and Ab antibody) as monotherapy for the treatment of patients with advanced relapsing/refractory (R/R) Hodgkin lymphoma. Read more... 

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.